The latest CSIR Profile Booklet (November 2026) is now available for download. Explore the strengths and achievements of CSIR laboratories.
https://t.co/3iZU1xcazb
๐ฐ ๐๐ฆ๐๐ฅ-๐๐ ๐ง๐๐๐ | ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ถ๐ป ๐๐ต๐ฒ ๐ฆ๐ฝ๐ผ๐๐น๐ถ๐ด๐ต๐
We are proud to share that research by Dr. Ramya T. N. C., Scientist G, and Ms. Shivangi, a Research Scholar working under her supervision at CSIR-IMTECH, has been featured on https://t.co/5M4P9vfs8w!
Congratulations to the researchers on their contribution to advancing our understanding of enzyme function!
๐ฅ๐ฒ๐ฎ๐ฑ ๐๐ต๐ฒ ๐ฐ๐ผ๐๐ฒ๐ฟ๐ฎ๐ด๐ฒ:
https://t.co/kRoUJq74B3
๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฝ๐๐ฏ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป:
https://t.co/ZX9sc6uoxA
@CSIR_IND@AcSIR_India
#CSIRIMTECH #CSIR #ScienceInTheNews #EnzymeResearch #Bioinformatics #Glycoscience #Biotechnology
Congratulations to Dr. Vinod Chaudhari & Team on acceptance of their Publication entitled "Benzoindole Derivatives as a New Class of Metallo-ฮฒ-Lactamase Inhibitors to Overcome Carbapenem Resistance" in the European Journal of Medicinal Chemistry.
It is indeed a proud moment for IMTech Family. Wish you many more such accomplishments.
@CSIR_IND@AcSIR_India
Team from Venus Remedies Limited, Panchkula led by Saransh Chaudhary, Executive Director, Venus Remedies Limited & CEO, Venus Medicine Research Centre visited CSIR-IMTECH today for exploring avenues for collaborative R&D, technology development and initiating industry aligned Skill Development programs, with a shared vision of translating scientific innovation into impactful solutions.
The scientific team of Venus Remedies Ltd. interacted with the Director and scientists of CSIR-IMTECH and visited state-of-the-art research facilities and technology platforms used for research and innovation.
The visit focused on fostering scientific collaboration and strengthening institutional association with CSIR-IMTECH and to strengthen Industry-Academia partnership.
@CSIR_IND@remediesvenus
#CSIR #IMTECH #VenusRemedies #ScientificResearch #Innovation #SkillDevelopment #Technology #HealthcareInnovation
Today, on World Cervical Cancer Elimination Day (17 November), CSIR-IMTECH proudly aligns with and champions the Government of Indiaโs national mandate to eliminate cervical cancer. With cervical cancer remaining a significant healthcare challenge, the Government of India has spear-headed crucial initiativesโfrom the national HPV vaccination campaign for adolescent girls to expanded screening services at primary healthcare centers nationwide.
At CSIR-IMTECH, as a premier research institute, we strongly support this national vision. We are committed to fostering awareness, supporting scientific progress, and championing the accessible healthcare and early detection pathways that will help realize a cervical cancer-free India.
Let us stand together in support of India's health missions to safeguard the well-being of women across the nation!
@CSIR_IND@MoHFW_INDIA@moayush #CervicalCancerEliminationDay #CervicalCancerFreeIndia #CSIRIMTECH #GoIMandate #ScienceForSociety #HPV #EarlyDetection #WomenHealth #IndiaFightsCancer #17November
Congratulations to Dr. Ramya T. N. C. & Team on acceptance of their Publication entitled "Exploring the tandem placement of carbohydrate-binding domains on the enzyme activity of Photobacterium damselae sialyltransferase and Pasteurella multocida sialyltransferase" in the International Journal of Biological Macromolecules.
It is indeed a proud moment for IMTech Family. Wish you many more such accomplishments.
@CSIR_IND@AcSIR_India
A renewed commitment to nurturing young scientific talent and strengthening Indiaโs research ecosystem.
Under the vision of Honโble PM Shri @narendramodi Ji, the redesigned INSPIRE-SHE scheme strengthens merit-based and inclusive opportunities in science education and research.
Applications for INSPIRE-SHE 2025, offering 12,000 scholarships, are open from 7 November to 7 December 2026.
CSIR-IMTECH is pleased to share that Dr. KPS Sengar, Head, KRC & Hindi Cell delivered an Invited Talk at the 6th LISACON 2026: International Conference on Libraries as Experience Centers, jointly organized by LIS Academy and Dr. Manmohan Singh Bengaluru City University from November 12โ14, 2026, in Bengaluru.
Speaking under Sub-theme 04 (AI Tools for Scholarly Publishing) on the topic "Strengthening Research Integrity in the Age of Artificial Intelligence: The Evolving Role of Librarians in Scholarly Communication," Dr. Sengar highlighted how rapid advancements in Generative AI are transforming academic publishing and why librarians are emerging as essential guardians of scientific trust.
He also showcased CSIR-IMTech's institutional best practices in strengthening research integrity, including the functioning of its robust Scientific Ethics Committee (SEC), the KRC's primary research data archiving workflow, and systematic pre-submission plagiarism and similarity screening using iThenticate.
The participation provided an opportunity to highlight CSIR-IMTech's proactive initiatives in fostering ethical research practices and reinforcing the role of knowledge resource centres in building a transparent, responsible, and trustworthy scholarly publishing ecosystem in the era of Artificial Intelligence.
@CSIR_IND
#CSIRIMTech #LISACON2026 #ResearchIntegrity #ArtificialIntelligence #GenerativeAI #ScholarlyCommunication #AcademicPublishing #ResearchEthics #LibrariesAsExperienceCenters
๐๐ป๐ฑ๐ถ๐ด๐ฒ๐ป๐ผ๐๐ ๐ฉ๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐ ๐๐ฎ๐ฝ๐ฎ๐ฏ๐ถ๐น๐ถ๐๐ถ๐ฒ๐ ๐ณ๐ผ๐ฟ ๐๐๐๐๐ฟ๐ฒ ๐ฃ๐ฎ๐ป๐ฑ๐ฒ๐บ๐ถ๐ฐ ๐ฃ๐ฟ๐ฒ๐ฝ๐ฎ๐ฟ๐ฒ๐ฑ๐ป๐ฒ๐๐ ๐ฎ๐ ๐๐ฆ๐๐ฅ-๐๐ป๐๐๐ถ๐๐๐๐ฒ ๐ผ๐ณ ๐ ๐ถ๐ฐ๐ฟ๐ผ๐ฏ๐ถ๐ฎ๐น ๐ง๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐
The research group led by ๐๐ฟ. ๐ฅ๐ฎ๐๐ถ ๐ฃ.๐ก. ๐ ๐ถ๐๐ต๐ฟ๐ฎ (๐ฆ๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐๐-๐) ๐ฎ๐ ๐๐ฆ๐๐ฅ-๐๐ ๐ง๐๐๐, ๐๐ต๐ฎ๐ป๐ฑ๐ถ๐ด๐ฎ๐ฟ๐ต, is advancing an indigenous protein subunit vaccine platform to strengthen national pandemic preparedness and response to emerging and re-emerging viral threats.
๐ฌ ๐ฉ๐ถ๐ฟ๐ฎ๐น ๐ฉ๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐ฃ๐น๐ฎ๐๐ณ๐ผ๐ฟ๐บ โ ๐๐ ๐ง-๐๐ฉ๐๐ซ (๐ง๐ฅ๐ ๐ฐ)
The platform is based on a recombinant, prefusion-stabilised trimeric SARS-CoV-2 spike protein produced using suspension CHO cells.
๐๐ฒ๐ ๐ง๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐ ๐๐ฐ๐ต๐ถ๐ฒ๐๏ฟฝ๏ฟฝ๐บ๐ฒ๐ป๐๐:
โข ๐๐๐ข-๐ฏ๐ฎ๐๐ฒ๐ฑ ๐ฒ๐ ๐ฝ๐ฟ๐ฒ๐๐๐ถ๐ผ๐ป: Recombinant trimeric spike protein production using mammalian cells.
โข ๐๐ถ๐ผ๐ฝ๐ฟ๐ผ๐ฐ๐ฒ๐๐ ๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐: Optimised upstream production and bioreactor scale-up, achieving approximately 500 mg/L yield.
โข ๐๐ผ๐๐ป๐๐๐ฟ๐ฒ๐ฎ๐บ ๐ฝ๐ฟ๐ผ๐ฐ๐ฒ๐๐๐ถ๐ป๐ด: Integrated purification using tangential flow filtration (TFF) and chromatography.
โข ๐ฃ๐ฟ๐ฒ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐๐ฎ๐น๐ถ๐ฑ๐ฎ๐๐ถ๐ผ๐ป: Strong immune responses and approximately 90% survival in the hamster challenge model.
โข ๐ง๐ฟ๐ฎ๐ป๐๐น๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐ฝ๐ผ๐๐ฒ๐ป๐๐ถ๐ฎ๐น: An industry-compatible production and purification workflow.
๐ ๐ฃ๐น๐ฎ๐๐ณ๐ผ๐ฟ๐บ ๐๐ฑ๐ฎ๐ฝ๐๐ฎ๐ฏ๐ถ๐น๐ถ๐๐ ๐ฎ๐ป๐ฑ ๐ฃ๐ฎ๐ป๐ฑ๐ฒ๐บ๐ถ๐ฐ ๐ฃ๐ฟ๐ฒ๐ฝ๐ฎ๐ฟ๐ฒ๐ฑ๐ป๐ฒ๐๐
The established CHO-based expression and bioprocess platform offers potential for developing recombinant protein subunit vaccine candidates against other emerging and re-emerging viruses with pandemic potential, including respiratory and zoonotic pathogens. Adaptation of antigen design and production processes could facilitate rapid vaccine proof-of-concept development during future public health emergencies.
๐ ๐๐ฒ๐ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฃ๐๐ฏ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป๐
Jitender et al. (2024). ๐๐ข๐ฎ๐ฎ๐ข๐ญ๐ช๐ข๐ฏ ๐ค๐ฆ๐ญ๐ญ ๐ฆ๐น๐ฑ๐ณ๐ฆ๐ด๐ด๐ฆ๐ฅ ๐ณ๐ฆ๐ค๐ฐ๐ฎ๐ฃ๐ช๐ฏ๐ข๐ฏ๐ต ๏ฟฝ๏ฟฝ๐ณ๐ช๐ฎ๐ฆ๐ณ๐ช๐ค ๐ด๐ฑ๐ช๐ฌ๐ฆ ๐ฑ๐ณ๐ฐ๐ต๐ฆ๐ช๐ฏ ๐ช๐ด ๐ข ๐ฑ๐ฐ๐ต๐ฆ๐ฏ๐ต ๐ท๐ข๐ค๐ค๐ช๐ฏ๐ฆ ๐ข๐ฏ๐ต๐ช๐จ๐ฆ๐ฏ ๐ข๐ฏ๐ฅ ๐ค๐ฐ๐ฏ๐ง๐ฆ๐ณ๐ด ๐ฏ๐ฆ๐ข๐ณ-๐ค๐ฐ๐ฎ๐ฑ๐ญ๐ฆ๐ต๐ฆ ๐ฑ๐ณ๐ฐ๐ต๐ฆ๐ค๐ต๐ช๐ฐ๐ฏ ๐ข๐จ๐ข๐ช๐ฏ๐ด๐ต ๐๐๐๐-๐๐ฐ๐-2 ๐ช๐ฏ๐ง๐ฆ๐ค๐ต๐ช๐ฐ๐ฏ ๐ช๐ฏ ๐๐ข๐ฎ๐ด๐ต๐ฆ๐ณ. ๐ฉ๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ, ๐ฐ๐ฎ(๐ฎ๐ฌ), ๐ญ๐ฎ๐ฒ๐ฌ๐ต๐ต.
Singh et al. (2024). ๐๐ค๐ข๐ญ๐ข๐ฃ๐ญ๐ฆ ๐ฃ๐ช๐ฐ๐ฑ๐ณ๐ฐ๐ค๐ฆ๐ด๐ด ๐ง๐ฐ๐ณ ๐ฉ๐ช๐จ๐ฉ-๐บ๐ช๐ฆ๐ญ๐ฅ ๐ฑ๐ณ๐ฐ๐ฅ๐ถ๐ค๐ต๐ช๐ฐ๐ฏ ๐ฐ๐ง ๐๐๐๐-๐๐ฐ๐-2 ๐ต๐ณ๐ช๐ฎ๐ฆ๐ณ๐ช๐ค ๐ด๐ฑ๐ช๐ฌ๐ฆ ๐ฑ๐ณ๐ฐ๐ต๐ฆ๐ช๐ฏ-๐ฃ๐ข๐ด๐ฆ๐ฅ ๐ช๐ฎ๐ฎ๐ถ๐ฏ๐ฐ๐จ๐ฆ๐ฏ (๐๐๐-๐๐๐๐) ๐ถ๐ด๐ช๐ฏ๐จ ๐ด๐ถ๐ด๐ฑ๐ฆ๐ฏ๐ด๐ช๐ฐ๐ฏ ๐๐๐ ๐ค๐ฆ๐ญ๐ญ๐ด. ๐ฃ๐ฟ๐ผ๐ฐ๐ฒ๐๐ ๐๐ถ๐ผ๐ฐ๐ต๐ฒ๐บ๐ถ๐๐๐ฟ๐, ๐ญ๐ฐ๐ณ, ๐ฏ๐ฏ๐ฎโ๐ฏ๐ฐ๐ฒ.
๐ ๐ฃ๐ฎ๐๐ฒ๐ป๐ ๐ฃ๐ผ๐ฟ๐๐ณ๐ผ๐น๐ถ๐ผ
โข ๐ช๐ข๐ฎ๐ฌ๐ฎ๐ฐ๐ฌ๐ฑ๐ฎ๐ต๐ฏ๐ด๐๐ญ: Process for recombinant production and purification of SARS-CoV-2 spike protein.
โข ๐๐ก ๐ฎ๐ฌ๐ฎ๐ฎ๐ญ๐ญ๐ฌ๐ฏ๐ฌ๐ญ๐ฐ๐ฌ: Recombinant protein for management of SARS-CoV-2 infection.
๐ฉ ๐๐ผ๐ป๐๐ฎ๐ฐ๐ ๐๐ฒ๐๐ฎ๐ถ๐น๐
๐๐ฟ. ๐ฅ๐ฎ๐๐ถ ๐ฃ.๐ก. ๐ ๐ถ๐๐ต๐ฟ๐ฎ
Scientist-F, CSIR-IMTECH, Chandigarh
โ๏ธ [email protected]n
@DrJitendraSingh @CSIR_IND @ravibhu5
#CSIR #CSIRIMTECH #IndigenousVaccines #VaccineDevelopment #PandemicPreparedness
๐๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป๐ ๐ข๐ฝ๐ฒ๐ป | ๐๐ฆ๐๐ฅ-๐๐ ๐ง๐๐๐ ๐ฆ๐ถ๐ -๐ ๐ผ๐ป๐๐ต ๐๐ถ๐๐๐ฒ๐ฟ๐๐ฎ๐๐ถ๐ผ๐ป ๐ง๐ฟ๐ฎ๐ถ๐ป๐ถ๐ป๐ด ๐ฃ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ ๐ฎ๐ฌ๐ฎ๐ณ
CSIR-Institute of Microbial Technology, Chandigarh, invites motivated undergraduate and postgraduate students to undertake their dissertation research under the mentorship of its scientists.
At CSIR-IMTECH, students can explore how proteins function, how microbes produce useful compounds through fermentation, or how computational tools reveal patterns in biological data. The institute brings together expertise in microbiology, protein science and engineering, immunology, fermentation technology and bioinformatics, supported by state-of-the-art laboratories and advanced computing facilities.
Each selected student will work on a focused research project with a faculty mentor, gain hands-on experience in experimental or computational methods, and learn to interpret and present their findings. Beyond the laboratory, IMTECHโs lush green campus in Chandigarh offers a lively academic environment where students can exchange ideas with scientists and fellow research scholars.
๐ง๐๐ผ ๐๐ฟ๐ฎ๐ถ๐ป๐ถ๐ป๐ด ๐ฐ๐๐ฐ๐น๐ฒ๐ | ๐ฏ๐ฌ ๐๐ฒ๐ฎ๐๐ ๐ฝ๐ฒ๐ฟ ๐ฐ๐๐ฐ๐น๐ฒ
๐๐๐ฐ๐น๐ฒ ๐ : JanuaryโJune 2027 Eligibility cut-off : 30 November 2026
๐๐๐ฐ๐น๐ฒ ๐๐ : JulyโDecember 2027 Eligibility cut-off : 30 May 2027
๐ View the detailed advertisement and apply online at https://t.co/OOp5pfmzql
@DrJitendraSingh@CSIR_IND
#CSIR #CSIRIntegratedSkillInitiative #SkillDevelopment #CSIRIMTECH #DissertationTraining #Biotechnology #StudentResearch
Understanding Pneumonia Through Scientific Research
Healthy lungs are the foundation of a healthier life! ๐ซ
On #WorldPneumoniaDay, let๏ฟฝ๏ฟฝs raise awareness about pneumonia, an infection that affects the lungs and disrupts oxygen exchange.
Research at @IGIBSocial , New Delhi, has explored the immune response and inflammatory mechanisms associated with bacterial pneumonia, contributing to a better understanding of the disease.
Vaccination, clean air, good hygiene and timely medical care remain essential in preventing and managing pneumonia.
Healthy Lungs. Stronger Lives.
@DrJitendraSingh @CSIR_IND
#PneumoniaAwareness #HealthAwareness
Congratulations to Dr. Saumya Raychaudhuri & Team on acceptance of their Publication entitled "L-Ascorbic AcidโMediated Transcriptomic and Physiological Responses in Vibrio cholerae" in the Journal Microorganisms.
It is indeed a proud moment for CSIR-IMTech Family. Wish you many more such accomplishments.
@DrJitendraSingh@CSIR_IND@AcSIR_India
Antimicrobial resistance (AMR) is an escalating global health challenge, calling for innovative preventive strategies alongside conventional antibiotic development.
๐๐ฎ๐ป ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ๐ ๐ฏ๐ฒ๐ฐ๐ผ๐บ๐ฒ ๐ฎ๐ป ๐ถ๐บ๐ฝ๐ผ๐ฟ๐๐ฎ๐ป๐ ๐ฝ๐ฎ๐ฟ๐ ๐ผ๐ณ ๐๐ต๐ฒ ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐ฟ๐ฒ๐๐ฝ๐ผ๐ป๐๐ฒ ๐๐ผ ๐๐ ๐ฅ?
The research group led by ๐๐ฟ. @๐ฅ๐ฎ๐๐ถ ๐ ๐ถ๐๐ต๐ฟ๐ฎ ๐ฎ๐ ๐๐ฆ๐๐ฅ-๐๐ ๏ฟฝ๏ฟฝ๐๐๐, ๐๐ต๐ฎ๐ป๐ฑ๐ถ๐ด๐ฎ๐ฟ๐ต, is advancing a novel protein subunit-based bacterial vaccine discovery platform with promising translational potential. The work, published in the peer-reviewed journal Vaccine (2026), highlights an unconventional approach to identifying and validating bacterial vaccine candidates.
๐ช๐ต๐ฎ๐ ๐ ๐ฎ๐ธ๐ฒ๐ ๐ง๐ต๐ถ๐ ๐๐ฝ๐ฝ๐ฟ๐ผ๐ฎ๐ฐ๐ต ๐ก๐ผ๐๐ฒ๐น?
โข AI-assisted reverse vaccinology: Systematic screening of bacterial proteomes to identify unexplored vaccine antigens.
โข Unconventional antigen discovery: Identification of SAUSA300_1684 (IMTS8), a previously uncharacterised hypothetical protein as a promising vaccine candidate.
โข Integrated development approach: Recombinant protein engineering, bioprocess scale-up and preclinical validation.
โข Experimental evidence: 84% survival in a murine model of MDR Staphylococcus aureus infection, compared with 11% in controls.
๐ฅ๐ฒ๐น๐ฒ๐๐ฎ๐ป๐ฐ๐ฒ ๐๐ผ ๐๐ผ๐บ๐ฏ๐ฎ๐๐ถ๐ป๐ด ๐๐ ๐ฅ
Vaccination can help prevent bacterial infections, potentially reduce antibiotic use and limit opportunities for the emergence and spread of resistance. This integrated discovery platform could be extended to explore vaccine candidates against other high-priority drug-resistant pathogens, including WHO-prioritised ESKAPE bacteria.
๐ง๐ต๐ฒ ๐ฏ๐ฟ๐ผ๐ฎ๐ฑ๐ฒ๐ฟ ๐๐ถ๐๐ถ๐ผ๐ป ๐ถ๐ ๐๐ผ ๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ ๐ถ๐ป๐ฑ๐ถ๐ด๐ฒ๐ป๐ผ๐๐, ๐๐ป๐ฐ๏ฟฝ๏ฟฝ๐ป๐๐ฒ๐ป๐๐ถ๐ผ๐ป๐ฎ๐น ๐ฏ๐ฎ๐ฐ๐๐ฒ๐ฟ๐ถ๐ฎ๐น ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐ถ๐ฒ๐ ๐๐ต๐ฎ๐ ๐ฐ๐ผ๐บ๐ฝ๐น๐ฒ๐บ๐ฒ๐ป๐ ๐ฎ๐ป๐๐ถ๐ฏ๐ถ๐ผ๐๐ถ๐ฐ๐ ๐ฎ๐ป๐ฑ ๐๐๐ฟ๐ฒ๐ป๐ด๐๐ต๐ฒ๐ป ๐๐ต๐ฒ ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐ฟ๐ฒ๐๐ฝ๐ผ๐ป๐๐ฒ ๐๐ผ ๐๐ ๐ฅ.
๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฃ๐๐ฏ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป/๐ฅ๐ฒ๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒ
Mishra, P.M. et al. (2026). A novel hypothetical protein (SAUSA300_1684) confers excellent protection against multi-drug-resistant Staphylococcus aureus infection in the murine model. Vaccine, 75, 128220. DOI: 10.1016/j.vaccine.2026.128220
@DrJitendraSingh @CSIR_IND
#CSIRIMTECH #AntimicrobialResistance #VaccineDevelopment #ReverseVaccinology #AntigenDiscovery #SubunitVaccines #StaphylococcusAureus
Congratulations to Dr. Ramya T. N. C. & Team on acceptance of their Publication entitled "Fucoidan and xyloglucan hydrolysis predicted by protein domain architecture in GH29 ฮฑ- L-fucosidases" in the journal Applied Microbiology and Biotechnology .
It is indeed a proud moment for CSIR-IMTech Family. Wish you many more such accomplishments.
@DrJitendraSingh@CSIR_IND@AcSIR_India